Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How to watch 'A Charlie Brown Christmas' for free in 2025 - 2Spain breaks jobs record with 22 million Social Security contributors
- 3'Here we go again': Businesses grapple with fuel costs
- 4Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'
- 5Holocaust survivor, descendants urge High Court to allow Gaza children medical access
- Instructions to Back Your Sunlight powered chargers: Tracking down Possible Choices
- ‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
- In vogue Sleepwear Patterns for 2024
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Pick Your Favored kind of sandwich
- A hunger for new experiences Narratives: Motivating Travel and Experience
- Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- People with depression can treat themselves at home with new device
